|
Pharmacology
Citations 1-10 of 165 total displayed.
|
Most recent content
(1 Dec 2009):
|
- CLINICAL
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
- Luca Quartuccio, Martina Fabris, Sara Salvin, Fabiola Atzeni, Marta Saracco, Maurizio Benucci, Marco Cimmino, Pia Morassi, Paola Masolini, Raffaele Pellerito, Maurizio Cutolo, Piercarlo Sarzi Puttini, and Salvatore De Vita
Rheumatology 2009; 48: 1557-1559.
[Abstract]
[Full Text]
- CLINICAL
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
- Marcus D. Köller, Daniel Aletaha, Julia Funovits, Aileen Pangan, Daniel Baker, and Josef S. Smolen
Rheumatology 2009; 48: 1575-1580.
[Abstract]
[Full Text]
- CLINICAL
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
- Chris T. Derk, Elizabeth Grace, Max Shenin, Manisha Naik, Steffan Schulz, and Wen Xiong
Rheumatology 2009; 48: 1595-1599.
[Abstract]
[Full Text]
- MATTERS ARISING
Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability
- Lorenzo Beretta
Rheumatology 2009; 48: 1619-a--a1620.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability: reply
- Thierry Dervieux
Rheumatology 2009; 48: 1620.
[Extract]
[Full Text]
|
Past content
(since Dec 2002):
|
- EDITORIALS
Registries in rheumatological and musculoskeletal conditions—call for papers
- David Isenberg, Roy Fleischmann, and Ulf Müeller-Ladner
Rheumatology 2009; 48: 1335-1336.
[Extract]
[Full Text]
- CLINICAL
Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil
- Giorgia Martini, Athimalaipet V. Ramanan, Fernanda Falcini, Hermann Girschick, Donald P. Goldsmith, and Francesco Zulian
Rheumatology 2009; 48: 1410-1413.
[Abstract]
[Full Text]
- CLINICAL
Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis
- Bernat Galarraga, Faisel Khan, Pradeep Kumar, Tom Pullar, and Jill J. F. Belch
Rheumatology 2009; 48: 1418-1423.
[Abstract]
[Full Text]
- CLINICAL
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial
- Martin Soubrier, Xavier Puéchal, Jean Sibilia, Xavier Mariette, Olivier Meyer, Bernarde Combe, René Marc Flipo, Denis Mulleman, Francis Berenbaum, Charles Zarnitsky, Thierry Schaeverbeke, Patrice Fardellone, and Maxime Dougados
Rheumatology 2009; 48: 1429-1434.
[Abstract]
[Full Text]
- CLINICAL
Adverse events and efficacy of TNF- blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
- Martin Aringer, Frederic Houssiau, Caroline Gordon, Winfried B. Graninger, Reinhard E. Voll, Eva Rath, Guenter Steiner, and Josef S. Smolen
Rheumatology 2009; 48: 1451-1454.
[Abstract]
[Full Text]
|
|
